Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Changes in Stockholders??? Equity (Unaudited)

v3.24.1.u1
Condensed Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   8,009,743    
Beginning balance at Dec. 31, 2022 $ 2,374 $ 1 $ 24,559 $ (22,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 393   393  
Sale of Common Stock, net of issuance costs (in shares)   206,289    
Sale of Common Stock, net of issuance costs 494   494  
Stock issuance upon vesting of restricted stock awards (in shares)   3,750    
Stock issuance upon exercise of Warrants (in shares)   7,292    
Stock issuance upon exercise of Warrants 16   16  
Net loss (4,136)     (4,136)
Ending balance (in shares) at Mar. 31, 2023   8,227,074    
Ending balance at Mar. 31, 2023 $ (859) $ 1 25,462 (26,322)
Beginning balance (in shares) at Dec. 31, 2023 26,329,032 26,329,032    
Beginning balance at Dec. 31, 2023 $ 15,937 $ 3 52,759 (36,825)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 1,207   1,207  
Net loss $ (4,606)     (4,606)
Ending balance (in shares) at Mar. 31, 2024 26,329,032 26,329,032    
Ending balance at Mar. 31, 2024 $ 12,538 $ 3 $ 53,966 $ (41,431)